Paper7923693
An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis.
Tanaka A and 3 others. Circulation, 1994. Cited by 49 papers, by iCite.
Cite this record
ConductScience Library. An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis. Papers, record 7923693. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7923693
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angiotensin Receptor Antagonists | Major topic |
| Benzimidazoles | Major topic |
| Biphenyl Compounds | Major topic |
| Heart | Major topic |
| Myocarditis | Major topic |
| Myocardium | Major topic |
| Tetrazoles | Major topic |
| Angiotensin II | |
| Animals | |
| Body Weight | |
| Cardiovirus Infections | |
| Disease Models, Animal | |
| Encephalomyocarditis virus | |
| Male | |
| Mice | |
| Mice, Inbred DBA | |
| Organ Size | |
| Survival Analysis | |
| Virus Replication |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37167363 | COVID-19, Myocarditis and Pericarditis. | Circ Res | 2023 | https://conductscience.org/library/papers/37167363 | PubMed |
| 34748384 | Telmisartan Restricts Chikungunya Virus Infection In Vitro and In Vivo through the AT1/PPAR-γ/MAPKs Pathways. | Antimicrob Agents Chemother | 2022 | https://conductscience.org/library/papers/34748384 | PubMed |
| 32567171 | The renin-angiotensin-aldosterone system as a link between obesity and coronavirus disease 2019 severity. | Obes Rev | 2020 | https://conductscience.org/library/papers/32567171 | PubMed |
| 32536978 | Dilated Cardiomyopathy Risk in Patients with Coronavirus Disease 2019: How to Identify and Characterise it Early? | Eur Cardiol | 2020 | https://conductscience.org/library/papers/32536978 | PubMed |
| 20676961 | Short-term effect of levosimendan on free light chain kappa and lambda levels in patients with decompensated chronic heart failure. | Heart Vessels | 2010 | https://conductscience.org/library/papers/20676961 | PubMed |
| 18087711 | Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats. | Graefes Arch Clin Exp Ophthalmol | 2008 | https://conductscience.org/library/papers/18087711 | PubMed |
| 17588693 | Comparison of angiotensin converting enzyme inhibition and angiotensin II receptor blockade for the prevention of experimental autoimmune myocarditis. | Int J Cardiol | 2008 | https://conductscience.org/library/papers/17588693 | PubMed |
| 15710982 | Amelioration of 2,4,6-trinitrobenzene sulphonic acid induced colitis in angiotensinogen gene knockout mice. | Gut | 2005 | https://conductscience.org/library/papers/15710982 | PubMed |
| 14694243 | Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist. | Thorax | 2004 | https://conductscience.org/library/papers/14694243 | PubMed |
| 11909009 | Diagnosis and management of pediatric myocarditis. | Paediatr Drugs | 2002 | https://conductscience.org/library/papers/11909009 | PubMed |
| 10606623 | Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. | J Clin Invest | 1999 | https://conductscience.org/library/papers/10606623 | PubMed |
| 9829158 | Candesartan cilexetil. A review of its use in essential hypertension. | Drugs | 1998 | https://conductscience.org/library/papers/9829158 | PubMed |
| 9590456 | Innovative drug treatments for viral and autoimmune myocarditis. | J Clin Pharmacol | 1998 | https://conductscience.org/library/papers/9590456 | PubMed |
| 8891464 | Recognition and optimum management of myocarditis. | Drugs | 1996 | https://conductscience.org/library/papers/8891464 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7923693
GET https://conductscience.org/api/papers/v1/7923693/authors